Regulatory Context for Allergy

Allergy-related healthcare in the United States sits within an overlapping framework of federal statutes, agency regulations, and state licensing structures. Understanding which bodies hold authority over allergy diagnosis, treatment, labeling, and workplace exposure determines how clinicians practice, how products reach patients, and how schools and employers manage risk. This page maps the governing sources, the federal-state division of power, the named agencies and their specific roles, and the pathways by which rules move from statute to clinical practice.

Governing sources of authority

The primary legal instruments shaping allergy care derive from four distinct layers: federal statutes enacted by Congress, federal regulations published in the Code of Federal Regulations (CFR), state medical practice acts, and administrative guidance documents issued by named agencies.

The Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA) is one of the most operationally significant federal statutes in this domain. FALCPA mandated plain-language disclosure for the 8 major allergens identified at enactment: milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, and soybeans. The FASTER Act of 2021 added sesame as the 9th major allergen, with compliance required by January 1, 2023. Detailed coverage of labeling obligations appears on the Food Allergy Labeling Laws page.

The Biologics Control Act and its successor provisions under 21 USC §351 govern allergen immunotherapy extracts as biological products, placing them under the FDA's Center for Biologics Evaluation and Research (CBER). Allergy testing reagents and diagnostic devices are regulated under 21 CFR Part 880 as medical devices.

Federal vs state authority structure

Federal authority dominates product regulation — drug approval, biologic licensure, and food labeling — while state authority governs the practice of medicine and the licensing of practitioners who diagnose and treat allergic disease.

The contrast is explicit:

Federal jurisdiction covers the manufacture and interstate sale of allergy medications, immunotherapy biologics, epinephrine auto-injectors, and allergen extracts. The FDA sets standards; the DEA schedules controlled substances used as adjuncts.
State jurisdiction covers physician licensure, scope-of-practice rules for allergists and immunologists, and the authority of mid-level practitioners (nurse practitioners, physician assistants) to order allergy testing or prescribe biologics such as dupilumab or omalizumab.
Shared or concurrent jurisdiction applies in occupational settings, where both the Occupational Safety and Health Administration (OSHA) under 29 CFR Part 1910 and state OSHA plans (operating in 22 states and 2 territories with their own plans) set permissible exposure limits for occupational allergens such as latex, isocyanates, and flour dust.
Education law operates at the intersection of federal and state authority: Section 504 of the Rehabilitation Act of 1973 and the Individuals with Disabilities Education Act (IDEA) require schools receiving federal funding to accommodate students with severe allergies, while state laws — such as those enacted in all 50 states permitting stock epinephrine in schools — add implementation layers.

Named bodies and roles

Multiple federal agencies hold distinct, non-overlapping mandates relevant to allergy:

U.S. Food and Drug Administration (FDA): Regulates allergen immunotherapy extracts, allergy diagnostic devices, OTC antihistamines, nasal corticosteroids, and food labeling. The FDA's CBER licenses standardized allergen extracts.
Centers for Disease Control and Prevention (CDC): Publishes surveillance data on asthma and allergic disease prevalence through the National Health Interview Survey (NHIS) and supports the National Asthma Control Program.
National Institute of Allergy and Infectious Diseases (NIAID): Funds and coordinates allergy research; publishes clinical practice guidelines, including the 2010 Guidelines for the Diagnosis and Management of Food Allergy in the United States (NIAID-sponsored expert panel).
OSHA: Sets permissible exposure limits under 29 CFR Part 1910.1000 for airborne sensitizers in occupational contexts, directly governing occupational allergies.
Centers for Medicare and Medicaid Services (CMS): Determines reimbursement policy for allergy testing (CPT codes 95004–95078) and immunotherapy, which effectively shapes access to diagnosis and treatment across the US population.

The American Board of Allergy and Immunology (ABAI), while not a government body, holds de facto authority over subspecialty certification for the approximately 7,000 board-certified allergists practicing in the United States.

How rules propagate

Federal statutes establish ceilings and floors; agencies translate those statutes into enforceable regulations through notice-and-comment rulemaking under the Administrative Procedure Act (5 USC §553). The pathway follows a defined sequence:

Congress enacts a statute (e.g., FALCPA).
The responsible agency (FDA) drafts implementing regulations, publishes them in the Federal Register for public comment, and finalizes them in the CFR.
Guidance documents — which are not legally binding but carry interpretive weight — clarify how the agency will enforce the regulation.
State legislatures and state medical boards adopt rules consistent with federal floors, adding state-specific requirements (e.g., mandatory epinephrine stock in schools, allergen disclosure rules for restaurants).
Professional societies such as the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Joint Council of Allergy, Asthma and Immunology (JCAAI) publish practice parameters that, while not regulations, are cited in malpractice standards and payer coverage decisions.

Patients and clinicians navigating this structure — from the allergy overview at the site index through specific topics such as anaphylaxis and allergy action plans — encounter rules originating at all five levels simultaneously.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)